Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells $2,350,250.00 in Stock

Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were sold at an average price of $67.15, for a total value of $2,350,250.00. Following the completion of the transaction, the director now directly owns 25,809 shares in the company, valued at approximately $1,733,074.35. This trade represents a 57.56 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Nicholas Dominic Cortezi also recently made the following trade(s):

  • On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.35, for a total transaction of $2,322,250.00.
  • On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00.
  • On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96.
  • On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The shares were sold at an average price of $65.00, for a total value of $5,915.00.
  • On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.17, for a total value of $2,280,950.00.
  • On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.71, for a total value of $2,334,850.00.
  • On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.39, for a total value of $2,358,650.00.

Ryan Specialty Stock Performance

RYAN stock traded up $0.13 during midday trading on Tuesday, reaching $66.73. 768,093 shares of the company’s stock traded hands, compared to its average volume of 1,051,816. Ryan Specialty Holdings, Inc. has a 52 week low of $42.21 and a 52 week high of $75.97. The company has a 50-day moving average price of $67.84 and a two-hundred day moving average price of $66.06. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a market capitalization of $17.47 billion, a PE ratio of 86.66, a price-to-earnings-growth ratio of 1.19 and a beta of 0.72.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm’s quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.32 EPS. As a group, equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.66%. Ryan Specialty’s dividend payout ratio is currently 57.14%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on RYAN. Keefe, Bruyette & Woods decreased their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research report on Friday, January 10th. The Goldman Sachs Group lifted their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research report on Wednesday, October 9th. Barclays raised their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and increased their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. Finally, Morgan Stanley began coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target on the stock. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Ryan Specialty presently has an average rating of “Hold” and a consensus target price of $74.40.

View Our Latest Research Report on Ryan Specialty

Institutional Trading of Ryan Specialty

Several institutional investors and hedge funds have recently bought and sold shares of RYAN. State Street Corp grew its position in Ryan Specialty by 1.5% in the third quarter. State Street Corp now owns 3,273,093 shares of the company’s stock worth $217,301,000 after acquiring an additional 49,198 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Ryan Specialty by 0.4% during the third quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company’s stock worth $209,058,000 after purchasing an additional 13,986 shares during the last quarter. Barclays PLC boosted its holdings in shares of Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after purchasing an additional 17,267 shares in the last quarter. Eagle Asset Management Inc. increased its position in shares of Ryan Specialty by 32.1% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock valued at $98,555,000 after purchasing an additional 335,180 shares during the last quarter. Finally, Jennison Associates LLC raised its holdings in shares of Ryan Specialty by 60.2% during the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after buying an additional 385,366 shares in the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

About Ryan Specialty

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Insider Buying and Selling by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.